FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/25/2025
Back to search
Official data from USPTO
GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
42
Filing date
04/04/2024
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
ARRISON, RACHEL MARIE
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a design of four curved lines in dark blue and turquoise partially around the stylized lettering "GCSA" in dark blue, a straight vertical dark blue line, and the wording "THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES" in dark blue.
Holders and representatives
Holders
Global Clinical Site Assessment Limited
Representatives
Bradley M. Stohry Reichel Stohry Dean LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Testinganalysisauditingevaluation of the services of others to determine conformity with certification standards in the field of clinical trials and clinical trial site competencypractices and processes; providing quality assurance services in the field of clinical trials and clinical trial site competencypractices and processes; quality control for others in the nature of quality checking in the field of clinical trial site competencypractices and processes; quality management servicesquality evaluation and analysisquality assurancequality controlin the field of clinical trial site competencypractices and processes; informationadvisory and consultancy in the field of certification standards of clinical trialsclinical trial site competencypractices and processes; informationadvisory and consultancy services in the field of quality assurance services of clinical trialsclinical trial site competencypractices and processes; informationadvisory and consultancy services in the field of quality control of clinical trialsclinical trial site competencypractices and processes; informationadvisory and consultancy services in the fields of quality management servicesquality evaluation and analysisquality assurancequality controlof clinical trial site competencypractices and processes
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2025
FIMP
FINAL DISPOSITION PROCESSED
12/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2025
RFNT
REFUSAL PROCESSED BY IB
11/17/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/31/2024
RFRR
REFUSAL PROCESSED BY MPU
10/31/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/26/2024
CNRT
NON-FINAL ACTION WRITTEN
10/25/2024
DOCK
ASSIGNED TO EXAMINER
10/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/04/2024
Continuous trademark protection
Get notified about every new filing that threatens GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.